← The Wire
LFVNNasdaq
Lifevantage Corp
Pharmaceutical Preparations · CIK 849146
LifeVantage develops and sells scientifically validated nutrigenomic products and supplements through a direct sales model
red 8-K · 90d
$114M
Market cap
$6.20
Last close
-6.3%
1D
+2.0%
5D
189K
Volume
Price · last 39 sessions+20.9%
May 4L $5.02 · H $10.70Jun 29
332
Total filings
May 6, 2026
Last filing
06/30
Fiscal year end
8-KResults of OperationsMay 6, 202610-Q10-QMay 6, 20268-KExecutive ChangeApr 16, 20268-KExecutive Change · Results of OperationsFeb 4, 202610-Q10-QFeb 4, 20268-KExecutive ChangeDec 9, 20258-KShareholder VoteNov 12, 20258-KResults of OperationsNov 4, 202510-Q10-QNov 4, 2025DEFA14ADEFA14ASep 19, 2025DEF 14ADEF 14ASep 19, 20258-KResults of OperationsSep 4, 202510-K10-KSep 4, 20258-KResults of OperationsMay 6, 202510-Q10-QMay 6, 20258-KResults of OperationsFeb 5, 202510-Q10-QFeb 5, 20258-KSecurity-Holder Rights · Bylaw AmendmentNov 19, 20248-KShareholder VoteNov 14, 20248-KResults of OperationsOct 29, 202410-Q10-QOct 29, 2024DEFA14ADEFA14ASep 20, 2024DEF 14ADEF 14ASep 20, 20248-KResults of OperationsAug 28, 202410-K10-KAug 28, 20248-KExecutive ChangeAug 26, 20248-KResults of OperationsMay 2, 202410-Q10-QMay 2, 20248-KMaterial Agreement · New Debt / ObligationApr 16, 20248-KExecutive Change · Material AgreementFeb 15, 20248-KResults of OperationsJan 30, 202410-Q10-QJan 30, 20248-K/AShareholder Vote · Company UpdateNov 13, 20238-KShareholder VoteNov 9, 20238-KResults of OperationsNov 9, 202310-Q10-QNov 9, 2023DEFA14ADEFA14AOct 30, 2023DEFA14ADEFA14AOct 25, 2023DEFA14ADEFA14AOct 18, 2023DEFA14ADEFA14AOct 16, 2023DEFA14ADEFA14AOct 16, 2023DEFA14ADEFA14AOct 13, 2023DEFA14ADEFA14AOct 10, 2023DEFA14ADEFA14AOct 10, 2023DEFA14ADEFA14AOct 5, 2023DEFA14ADEFA14AOct 2, 2023DEFA14ADEFA14ASep 25, 20238-KMaterial Agreement · Security-Holder RightsAug 31, 20238-KResults of OperationsAug 28, 202310-K10-KAug 28, 2023DEFA14ADEFA14AAug 14, 20238-KCompany UpdateAug 14, 20238-KCompany UpdateJun 13, 2023SC 13DTHE SCHEDULE 13DMay 15, 20238-KResults of OperationsMay 4, 202310-Q10-QMay 4, 20238-KAuditor ChangeApr 17, 20238-KExecutive ChangeMar 23, 20238-KAuditor ChangeFeb 16, 20238-KResults of OperationsFeb 2, 202310-Q10-QFeb 2, 20238-KCompany UpdateJan 19, 20238-K/AShareholder VoteNov 18, 20228-KShareholder VoteNov 17, 20228-KResults of OperationsNov 2, 202210-Q10-QNov 2, 2022DEFA14ADEFA14ASep 30, 2022DEF 14ADEF 14ASep 30, 2022SC 13DSCHEDULE 13DSep 6, 20228-KResults of OperationsAug 23, 202210-K10-KAug 23, 20228-KResults of OperationsMay 3, 202210-Q10-QMay 3, 20228-KExecutive ChangeMar 11, 20228-KExecutive ChangeFeb 17, 20228-KResults of OperationsFeb 1, 202210-Q10-QFeb 1, 20228-KShareholder VoteNov 15, 20218-KResults of OperationsNov 4, 202110-Q10-QNov 4, 2021
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 16, 2026: 2 insiders bought $179K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Lewis DarwinDirector | Buy | 1,055 | $5.23 | $6K |
| Mar 2, 2026 | Dayton JuddDirector | Buy | 10,500 | $4.53 | $48K |
| Feb 27, 2026 | Dayton JuddDirector | Buy | 18,097 | $4.63 | $84K |
| Feb 26, 2026 | Dayton JuddDirector | Buy | 4,600 | $4.58 | $21K |
| Feb 9, 2026 | Lewis DarwinDirector | Buy | 3,955 | $5.22 | $21K |
| Dec 15, 2025 | Lewis DarwinDirector | Buy | 805 | $6.54 | $5K |
| Nov 19, 2025 | Beindorff Michael ADirector | Sell | 12,607 | $6.42 | $81K |
| Nov 7, 2025 | Beindorff Michael ADirector | Sell | 35,000 | $6.92 | $242K |
| Nov 7, 2025 | Beindorff Michael ADirector | Sell | 1,000 | $7.33 | $7K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance